What is the current stock price of Crinetics Pharmaceuticals, Inc.?

As of the latest update, Crinetics Pharmaceuticals, Inc.'s stock is trading at $34.73 per share.

What's happening with Crinetics Pharmaceuticals, Inc. stock today?

Today, Crinetics Pharmaceuticals, Inc. stock is down by 1.12%, possibly due to recent market activity.

What is the market sentiment around Crinetics Pharmaceuticals, Inc. stock?

Current sentiment around Crinetics Pharmaceuticals, Inc. stock is neutral, based on recent news, trading volume, and analyst opinions.

Is Crinetics Pharmaceuticals, Inc.'s stock price growing?

Over the past month, Crinetics Pharmaceuticals, Inc.'s stock price has decreased by 9.36%.

How can I buy Crinetics Pharmaceuticals, Inc. stock?

You can buy Crinetics Pharmaceuticals, Inc. stock through any brokerage platform, such as Robinhood, Fidelity, or E*TRADE, by searching for the ticker symbol CRNX.

Who are the major shareholders of Crinetics Pharmaceuticals, Inc. stock?

Major shareholders of Crinetics Pharmaceuticals, Inc. include institutions such as FMR LLC, The Vanguard Group, Inc., Wellington Management Group LLP, according to the latest filings.

CRNX

Crinetics Pharmaceuticals Inc

$34.73

1.12%

Trade Ideas Performance

Latest Closed Trade Idea

$34.73

1.12%

We are loading your data. Please wait a moment.

Sentiment

News

Social

About

Events of Crinetics Pharmaceuticals Inc (CRNX)

Over the past six months, the FDA approved PALSONIFY in September 2025, leading to a U.S. commercial launch in Q4 2025, generating $5.4 million in net product revenue, and $10.3 million in Q1 2026. Crinetics reported its Q4 2025 financial results on February 26, 2026, after which CRNX shares declined by 6.0%. On May 7, 2026, Crinetics reported Q1 2026 revenue of $10.7 million, exceeding forecasts, and an EPS of -$1.23, surpassing expectations, causing the stock to rise 4.27% in after-hours trading. In March 2026, Crinetics submitted a Marketing Authorization Application for PALSONIFY in Brazil, and the European Commission approved PALSONIFY for acromegaly in adults. Between April 7, 2025, and April 2, 2026, the share price increased by 41.13%. As of May 8, 2026, the stock price was $37.48, representing a 22.16% increase over the past year. In March 2026, the CEO and CFO sold shares at average prices of $37.37 and $39.67, respectively.

Related Assets

Price action provided by Massive. Fundamentals, news and corporate events provided by FactSet. NLP support provided by Perplexity & Gemini. All data is provided for informational purposes only.

What Is Online Stock Trading and How Does the Market Work?

Online stock trading allows you to buy and sell shares of companies using digital platforms — all from your computer or phone. When you purchase a stock, you’re buying a small piece of that company. If the company performs well, its stock price usually goes up, and your investment gains value. If it struggles, the stock price may fall. All of this happens on stock exchanges, like the New York Stock Exchange or Nasdaq. These are marketplaces where investors and traders come together electronically. Prices change constantly based on supply and demand — the more people want a stock, the higher the price. If more people are selling, the price usually drops. Today, tools like Edge Hound, a generative AI trading assistant, make it easier for beginners to understand market trends and stay informed. What once required hours of manual research can now be streamlined using AI-powered insights.

Make every trade make sense.

Get started for FREE

Join us and trade with people
who think like you.

The Edge Hound Discord is where serious self-directed investors talk strategy, share setups, and learn from each other. Free to join with any plan - including Free.

Free to join with any plan - including Free.

Join our Discord community